Hyderabad Telangana, India

Puli Narender

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2010.


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Puli Narender: Innovator in Antimalarial Compounds

Introduction

Puli Narender is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antimalarial compounds. His work focuses on synthesizing novel compounds that exhibit remarkable anti-malarial activity.

Latest Patents

Puli Narender holds a patent for "Antimalarial Baylis-Hillman adducts and a process for the preparation thereof." This invention is directed towards the synthesis of new chloropyridine skeleton-based compounds, specifically Baylis-Hillman adducts. These compounds have demonstrated significant in vitro anti-malarial activity against both chloroquine-sensitive and chloroquine-resistant strains. The anti-malarial compounds inhibit mature schizonts in vitro, showcasing their potential as effective treatments.

Career Highlights

Puli Narender is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in medicinal chemistry. His dedication to innovation in the field has led to the development of compounds that could play a crucial role in combating malaria.

Collaborations

He has collaborated with notable colleagues, including Banda Gangadasu and Uppalanchi Srinivas, to further enhance the research and development of antimalarial compounds.

Conclusion

Puli Narender's contributions to the field of antimalarial research highlight his innovative spirit and commitment to addressing global health challenges. His work not only advances scientific knowledge but also has the potential to impact public health positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…